The WISeR program represents more than a narrow CMS innovation test; it is a live experiment in algorithmic gatekeeping that could normalize AI denial systems across traditional Medicare. While STAT News correctly highlights Democratic resolutions under the Congressional Review Act and GAO findings that the model required legislative approval, the coverage underplays how payment incentives tied to denial volume echo documented patterns in Medicare Advantage, where prior authorization has been linked to care delays in observational studies of over 1.5 million beneficiaries. A 2023 Health Affairs analysis of MA plans found that prior auth requirements disproportionately affected post-acute care and durable medical equipment—precisely the categories targeted by WISeR—yet relied on administrative claims data without randomized controls, leaving causal impact on health outcomes uncertain. CMS Administrator Oz’s assurance of post-hoc audits fails to address core transparency gaps: no public details exist on the AI models’ training data, bias audits, or false-negative rates for denied services. This omission risks repeating failures seen in commercial AI tools, where observational reviews have shown up to 20% discordance with clinician judgment. If scaled, WISeR could accelerate privatization pressures by embedding denial infrastructure directly into fee-for-service Medicare, a connection Democratic critics correctly flag but which lacks supporting longitudinal data on patient harm. Broader precedent-setting for AI in coverage decisions remains the highest-stakes element, as successful implementation would likely influence state Medicaid programs and commercial insurers lacking similar oversight mechanisms.